What is Ascletis Pharma Inc. (1672.HK) stock price today?

Ascletis Pharma Inc. (1672.HK) is currently trading at $10.80, up 8.32% today.

HKG · —

Ascletis Pharma Inc. (1672.HK) Stock

$10.80 +8.32% HKG: 1672.HK —

Valuation

Metric	Value
Price	$10.80
Market Cap	—
P/E Ratio	—
P/B Ratio	—
P/S Ratio	—
EPS (TTM)	—
52-Week High	$19.86
52-Week Low	$7.95
Dividend Yield	—

Financials & Margins

Metric	Value
ROE	—
ROA	—
ROCE	—
Gross Margin	—
Operating Margin	—
Net Margin	—
Debt/Equity	—
Current Ratio	—

Latest News

Hillcore to build 2.6GW power complex at Fermi Matador site in US Power Technology · Aug 13, 2026 Critical Elements updates on Rose West assay results in Québec Mining Technology · Aug 13, 2026 Australia, NSW governments commit $1.76bn to Tomago Aluminium Mining Technology · Aug 13, 2026 Scatec starts commercial operations for Obelisk solar project in Egypt Power Technology · Aug 13, 2026 Japan protests Putin's first visit to disputed islands AFP · Aug 13, 2026

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	-18.66
FCF Yield	—
Quick Ratio	15.00
Interest Coverage	—
Return 1Y	-32.00%
Return 3Y	508.52%
Return 5Y	278.45%

Ownership

Insiders Held65.76%

Institutions Held12.64%

Institutions Float Held36.92%

Institutional Holder	Shares	Report Date
iShares, Inc.-iShares Core MSCI Emerging Markets ETF	2,352,000	2026-06-30
Roundhill ETF Trust-Roundhill GLP-1 & Weight Loss ETF	1,133,000	2026-03-31
SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Emerging Markets ETF	714,000	2026-06-30
Invesco Exch-Trd Fd. TRT II-Invesco Intl BuyBack Achievers ETF	191,105	2026-06-30
Fidelity Salem Street Trust-Fidelity Total International Index Fund	216,000	2026-06-30

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
0775.HKCK Life Sciences Int'l., (Holdings) Inc.	$0.56	-1.75%	-28.00	$5.33B	0.00%
1477.HKOcumension Therapeutics	$5.35	+5.52%	—	—	0.00%
2142.HKHBM Holdings Limited	$15.03	+19.19%	—	—	0.00%
2157.HKLepu Biopharma Co., Ltd.	$4.60	+8.49%	—	—	0.00%
2171.HKCARsgen Therapeutics Holdings Limited	$15.82	+12.20%	—	—	0.00%

About Ascletis Pharma Inc.

Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is based in Hangzhou, the People’s Republic of China.

Ascletis Pharma Inc. is led by CEO Jinzi J. Wu, employs 202 people, headquartered in Hangzhou, CN, publicly traded since 2018.

over the past 52 weeks the stock has ranged between $7.95 and $19.86, and currently trades 45.6% below its 52-week high.

Official website: www.ascletis.com

Related — Stocks

BNY — $152.52 -2.54% CIEN — $412.39 +2.14% CBRS — $188.61 -5.28% HEI.A AIRCRAFT ENGINES & ENGINE PARTS $216.35 +0.00% LEN.B GENERAL BLDG CONTRACTORS - RESIDENTIAL BLDGS $80.32 +0.00% WSO.B WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES $453.37 +0.00% MKC.V MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS $51.78 +0.00% MOG.B MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $322.00 +0.00% MOG.A MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $307.91 +0.00% UHAL.B SERVICES-AUTO RENTAL & LEASING (NO DRIVERS) $45.71 +0.00% TAP.A MALT BEVERAGES $47.89 +0.00% VSXY — $88.68 +0.50%

Screens featuring this stock

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Run Stock Screener Investing Guides